NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹541 Cr | ₹316 Cr | ₹374 Cr | ₹362 Cr | ₹234 Cr |
What is the latest Sundry Debtors ratio of NEULAND LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹541 Cr |
| Mar2025 | ₹316 Cr |
| Mar2024 | ₹374 Cr |
| Mar2023 | ₹362 Cr |
| Mar2022 | ₹234 Cr |
How is Sundry Debtors of NEULAND LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹541 Cr | 71.47 | |
| Mar2025 | ₹316 Cr | -15.48 | |
| Mar2024 | ₹374 Cr | 3.25 | |
| Mar2023 | ₹362 Cr | 54.39 | |
| Mar2022 | ₹234 Cr | - | |
Compare Sundry Debtors of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹25,620.1 Cr | 5.8% | -8.6% | 18.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 5.8% |
-8.6% |
18.9% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses